abstract |
The present invention provides a biomarker for quickly and accurately diagnosing familial Mediterranean fever during the seizure period. [MEANS FOR SOLVING PROBLEMS] A biomarker for distinguishing between a healthy subject and a familial Mediterranean fever patient, comprising: (a) an IL-6 protein or an IL-6 transcript, comprising the following (a) to (d): ) ICAM-1 protein or ICAM-1 transcript, (c) IL-18 protein or IL-18 transcript, (d) IL-17 protein or IL-17 transcript. [Selection figure] None |